• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度阿萨姆邦古瓦哈蒂市新冠肺炎老年患者的临床流行病学概况:一项横断面研究

Clinico-Epidemiological Profiles of COVID-19 Elderly Patients in Guwahati City, Assam, India: A Cross-Sectional Study.

作者信息

Patgiri Priyanka Rana, Rajendran Vinoth, Ahmed Abdul B

机构信息

Geriatrics, Regional Geriatric Centre, Gauhati Medical College & Hospital, Guwahati, IND.

Community Medicine & Family Medicine, All India Institute of Medical Sciences, Jodhpur, Jodhpur, IND.

出版信息

Cureus. 2022 Apr 11;14(4):e24043. doi: 10.7759/cureus.24043. eCollection 2022 Apr.

DOI:10.7759/cureus.24043
PMID:35573552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9094510/
Abstract

Background As of November 14, 2021, coronavirus disease 2019 (COVID-19 has affected more than 3,44,00,000 individuals in India and resulted in more than 4,60,000 deaths in India.Symptoms of COVID-19 include cough, fever, dyspnea, diarrhea, fatigue, expectoration, myalgia, hemoptysis, abdominal pain, and anorexia.Associated comorbidities such as hypertension, diabetes, cardiovascular illness, and respiratory sicknesses influence the severity and prognosis of the COVID-19. Therefore, this study was conducted to determine the factors associated with the severity and outcome of elderly Indian people diagnosed with COVID-19. Methodology This hospital-based descriptive cross-sectional study was conducted among elderly patients with confirmed COVID-19 who were admitted to Gauhati Medical College Hospital from July 21, 2020, to January 15, 2021. The demographic data, exposure history, clinical symptoms and signs, underlying comorbidity, severity of COVID-19, and outcome data of each elderly patient were obtained and analyzed using SPSS software (Version 25.0, IBM Corp., Armonk, NY). The Fisher exact test, chi-square test, and binary logistic regression analysis were used for different study variables. Result A total of 165 hospitalized COVID-19 elderly patients were included in this study, and their mean age was 68.4 years. The most common symptoms were cough (34.5%), fever (28%), breathing difficulty (22%), weakness (13.1%), and chest pain (3.6%). Those with breathing difficulty (adjusted OR [aOR]: 7.293, 95% CI: 2.229-23.860, p=0.001), loose stool (aOR: 12.142, 95% CI: 1.052-140.209, p=0.045), hypertension (aOR: 2.703, 95% CI: 1.023-7.139, p=0.045), and severity of COVID-19 (aOR: 7.691, 95% CI: 2.870-20.607, P<0.001) had increased risk of poor outcome among the COVID-19 elderly. Being hypertensive (aOR: 2.474, 95% CI: 1.060-5.774, p=0.036) had an increased risk of severity of COVID-19. Conclusion The most common symptoms of COVID-19 elderly patients were fever, cough, and breathing difficulty. In elderly COVID-19 patients, hypertension played a crucial role in determining the severity of COVID-19, whereas breathing difficulty, loose stool, hypertension, and moderate-to-severe COVID-19 elderly patients had a poor outcome.

摘要

背景 截至2021年11月14日,2019冠状病毒病(COVID-19)已在印度感染了超过3440万人,并导致印度超过46万人死亡。COVID-19的症状包括咳嗽、发热、呼吸困难、腹泻、疲劳、咳痰、肌痛、咯血、腹痛和厌食。高血压、糖尿病、心血管疾病和呼吸系统疾病等相关合并症会影响COVID-19的严重程度和预后。因此,本研究旨在确定与确诊为COVID-19的印度老年人的严重程度和预后相关的因素。

方法 本基于医院的描述性横断面研究在2020年7月21日至2021年1月15日入住高哈蒂医学院医院的确诊COVID-19老年患者中进行。获取每位老年患者的人口统计学数据、接触史、临床症状和体征、基础合并症、COVID-19的严重程度和结局数据,并使用SPSS软件(版本25.0,IBM公司,纽约州阿蒙克)进行分析。对不同的研究变量使用Fisher精确检验、卡方检验和二元逻辑回归分析。

结果 本研究共纳入165例住院的COVID-19老年患者,他们的平均年龄为68.4岁。最常见的症状是咳嗽(34.5%)、发热(28%)、呼吸困难(22%)、虚弱(13.1%)和胸痛(3.6%)。呼吸困难者(调整后比值比[aOR]:7.293,95%置信区间[CI]:2.229-23.860,p=0.001)、腹泻者(aOR:12.142,95%CI:1.052-140.209,p=0.045)、高血压患者(aOR:2.703,95%CI:1.023-7.139,p=0.045)以及COVID-19严重程度较高者(aOR:7.691,95%CI:2.870-20.607,P<0.001)在COVID-19老年患者中预后不良的风险增加。高血压患者(aOR:2.474,95%CI:1.060-5.774,p=0.036)发生COVID-19严重程度增加的风险增加。

结论 COVID-19老年患者最常见的症状是发热、咳嗽和呼吸困难。在老年COVID-19患者中,高血压在确定COVID-19的严重程度方面起关键作用,而呼吸困难、腹泻、高血压以及中重度COVID-19老年患者预后不良。

相似文献

1
Clinico-Epidemiological Profiles of COVID-19 Elderly Patients in Guwahati City, Assam, India: A Cross-Sectional Study.印度阿萨姆邦古瓦哈蒂市新冠肺炎老年患者的临床流行病学概况:一项横断面研究
Cureus. 2022 Apr 11;14(4):e24043. doi: 10.7759/cureus.24043. eCollection 2022 Apr.
2
A Study of Symptomatology of COVID-19 Laboratory-Confirmed Cases at Tertiary Care Center: A Cross-Sectional Study.三级医疗中心新冠病毒实验室确诊病例症状学研究:一项横断面研究。
Cureus. 2022 Feb 13;14(2):e22186. doi: 10.7759/cureus.22186. eCollection 2022 Feb.
3
An Assessment of the Profile and Predictors of Outcomes in COVID-19 Patients Hospitalized in a Tertiary Care Institute in Central India.对印度中部一家三级医疗机构收治的新冠肺炎患者的概况及预后预测因素的评估
Cureus. 2022 Jul 16;14(7):e26909. doi: 10.7759/cureus.26909. eCollection 2022 Jul.
4
Exploring the Clinical Features, Management of Hypertension, and Predictors of Severity in Hospitalized Hypertensive COVID-19 Patients.探索住院的高血压COVID-19患者的临床特征、高血压管理及严重程度预测因素。
Cureus. 2024 May 30;16(5):e61356. doi: 10.7759/cureus.61356. eCollection 2024 May.
5
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
6
Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases.年龄、性别、合并症及临床症状对新型冠状病毒肺炎病例严重程度的影响:一项纳入55项研究及10014例病例的荟萃分析
Heliyon. 2020 Dec;6(12):e05684. doi: 10.1016/j.heliyon.2020.e05684. Epub 2020 Dec 15.
7
Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province.新冠病毒病严重程度的症状预后识别:河南省一组病例的多变量数据分析
J Med Internet Res. 2020 Jun 30;22(6):e19636. doi: 10.2196/19636.
8
Disease Outcomes of COVID-19 in Diabetic and Hypertensive Patients During the Hospital Stay.糖尿病和高血压患者住院期间新冠病毒病的疾病转归
Cureus. 2023 Oct 13;15(10):e46943. doi: 10.7759/cureus.46943. eCollection 2023 Oct.
9
Trends and clinico-epidemiological profile of COVID-19 patients at a designated COVID-19 hospital in Delhi, North India.印度北部德里一家指定的新冠肺炎医院中新冠肺炎患者的趋势及临床流行病学概况。
J Family Med Prim Care. 2020 Dec 31;9(12):6261-6266. doi: 10.4103/jfmpc.jfmpc_1267_20. eCollection 2020 Dec.
10
Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.中国武汉 1663 例 COVID-19 住院患者的流行病学和临床特征:一项单中心经验。
J Infect Public Health. 2020 Sep;13(9):1202-1209. doi: 10.1016/j.jiph.2020.07.002. Epub 2020 Jul 17.

引用本文的文献

1
Perception and Attitude Towards COVID-19 Vaccination Among the Elderly: A Community-Based Cross-Sectional Study.老年人对新冠疫苗接种的认知与态度:一项基于社区的横断面研究
Cureus. 2022 Dec 29;14(12):e33108. doi: 10.7759/cureus.33108. eCollection 2022 Dec.
2
Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis.合并哮喘增加亚洲地区2019冠状病毒病死亡风险:一项荟萃分析
Vaccines (Basel). 2022 Dec 30;11(1):89. doi: 10.3390/vaccines11010089.

本文引用的文献

1
Factors Associated with Mortality among Elderly People in the COVID-19 Pandemic (SARS-CoV-2): A Systematic Review and Meta-Analysis.与 COVID-19 大流行(SARS-CoV-2)期间老年人死亡率相关的因素:系统评价和荟萃分析。
Int J Environ Res Public Health. 2021 Jul 29;18(15):8008. doi: 10.3390/ijerph18158008.
2
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis.糖尿病是 COVID-19 住院患者死亡的最重要原因:系统评价和荟萃分析。
Rev Endocr Metab Disord. 2021 Jun;22(2):275-296. doi: 10.1007/s11154-021-09630-8. Epub 2021 Feb 22.
3
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study.合并症对 COVID-19 严重程度的预后价值:一项系统评价和荟萃分析研究。
PLoS One. 2021 Feb 16;16(2):e0246190. doi: 10.1371/journal.pone.0246190. eCollection 2021.
4
Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis.高血压是 COVID-19 患者发生重症和死亡的一个重要临床危险因素:一项荟萃分析。
Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):745-755. doi: 10.1016/j.numecd.2020.12.009. Epub 2020 Dec 11.
5
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.二甲双胍治疗 COVID-19 住院患者的死亡率风险:一项回顾性队列分析。
Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 3.
6
Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis.中国轻、重症 COVID-19 患者临床症状差异的 Meta 分析。
Front Public Health. 2021 Jan 14;8:561264. doi: 10.3389/fpubh.2020.561264. eCollection 2020.
7
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.意大利伦巴第地区某学术医院的 2 型糖尿病合并 COVID-19 患者的合并症和入院时血糖以及二肽基肽酶 4 抑制剂的影响:一项病例系列研究。
Diabetes Care. 2020 Dec;43(12):3042-3049. doi: 10.2337/dc20-1340. Epub 2020 Oct 6.
8
First confirmed case of COVID-19 infection in India: A case report.印度首例新冠肺炎确诊病例:病例报告
Indian J Med Res. 2020 May;151(5):490-492. doi: 10.4103/ijmr.IJMR_2131_20.
9
Smoking Is Associated With COVID-19 Progression: A Meta-analysis.吸烟与 COVID-19 进展相关:一项荟萃分析。
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656. doi: 10.1093/ntr/ntaa082.
10
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.